Results 161 to 167 of about 5,967 (167)

NTRK Fusion-positive Non–small-cell Lung Cancer: The Diagnosis and Targeted Therapy

Clinical Lung Cancer, 2021
Takashi Seto
exaly  

NTRK FUSION MOLECULES AND USES THEREOF

2021
DARCY CHRISTOPHER, CLASSON ANTHONY, SOKOL ETHAN SAMUEL, LIU XIN, GORNSTEIN ERICA, ROSENZWEIG MARK, ERBACH RACHEL   +6 more
openaire   +2 more sources

Entrectinib in patients with advanced or metastatic NTRK fusion-positive solid tumours: integrated analysis of three phase 1–2 trials

Lancet Oncology, The, 2020
Anna F Farago, Robert C Doebele, George D Demetri   +2 more
exaly  

Entrectinib bei NTRK-Fusion-positiven Tumoren

Im Focus Onkologie, 2018
openaire   +2 more sources

Entrectinib for ROS1 fusion-positive NSCLC and NTRK fusion-positive solid tumours

The Lancet Oncology, 2020
openaire   +3 more sources

IDENTIFICATION OF CANDIDATE SIGNS INDICATIVE OF AN NTRK ONCOGENIC FUSION

2020
SCHMITZ ARNDT, ELCI EREN METIN, STAVROPOULOU FAIDRA, KACHALA MIKHAIL, KARLSSON ANTTI, TUKIAINEN MIKKO   +5 more
openaire   +3 more sources

Diagnosing NTRK fusions in lung and thyroid cancer.

Clinical advances in hematology & oncology : H&O
openaire   +1 more source